These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22472984)

  • 1. Off-label drug use in pediatric patients.
    Kimland E; Odlind V
    Clin Pharmacol Ther; 2012 May; 91(5):796-801. PubMed ID: 22472984
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacotherapy for pediatric cardiovascular diseases: the role of off-label drug use in the 21st century.
    Ring JC
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):69-71. PubMed ID: 20031791
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring the safety of medicines used off-label.
    Dal Pan GJ
    Clin Pharmacol Ther; 2012 May; 91(5):787-95. PubMed ID: 22472983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Off-label drugs use in children--clinical perspective].
    Kwinta P
    Przegl Lek; 2011; 68(1):1-3. PubMed ID: 21563434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug development: The use of unlicensed/off-label medicines in pediatrics.
    Yamashiro Y; Martin J; Gazarian M; Kling S; Nakamura H; Matsui A; Cucchiara S; Aloi M; Wynn EL; Mulberg AE
    J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):506-10. PubMed ID: 22983373
    [No Abstract]   [Full Text] [Related]  

  • 6. Off-label and unlicensed medication use and associated adverse drug events in a pediatric emergency department.
    Phan H; Leder M; Fishley M; Moeller M; Nahata M
    Pediatr Emerg Care; 2010 Jun; 26(6):424-30. PubMed ID: 20502385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controversies with the "off label" use of medications in the paediatrics--research on the selected paediatricians].
    Kuchar E; Szenborn L; Rorat M; Jurek T
    Przegl Lek; 2010; 67(1):28-30. PubMed ID: 20509568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-label use and prescribing: what does it mean for the foot and ankle surgeon?
    Hyer CF
    Foot Ankle Spec; 2010 Oct; 3(5):303-6. PubMed ID: 20966455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel.
    Gavrilov V; Lifshitz M; Levy J; Gorodischer R
    Isr Med Assoc J; 2000 Aug; 2(8):595-7. PubMed ID: 10979352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. France's new framework for regulating off-label drug use.
    Emmerich J; Dumarcet N; Lorence A
    N Engl J Med; 2012 Oct; 367(14):1279-81. PubMed ID: 23034018
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pediatric pharmacology and use of unapproved drugs (off label)].
    Giglio N
    Arch Argent Pediatr; 2012; 110(1):5. PubMed ID: 22307415
    [No Abstract]   [Full Text] [Related]  

  • 13. Off label use of prescription medicines in children in outpatient setting in Estonia is common.
    Lass J; Irs A; Pisarev H; Leinemann T; Lutsar I
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):474-81. PubMed ID: 21416552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label prescribing patterns of antidepressants in children and adolescents.
    Lee E; Teschemaker AR; Johann-Liang R; Bazemore G; Yoon M; Shim KS; Daniel M; Pittman J; Wutoh AK
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):137-44. PubMed ID: 21538674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uses of drugs not described in the package insert (off-label uses).
    Committee on Drugs. American Academy of Pediatrics
    Pediatrics; 2002 Jul; 110(1 Pt 1):181-3. PubMed ID: 12093968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["Off-label" prescribing of drugs in the ambulatory care of children and adolescents].
    Bücheler R; Meisner C; Kalchthaler B; Mohr H; Schröder H; Mörike K; Schwoerer P; Schwab M; Gleiter CH
    Dtsch Med Wochenschr; 2002 Nov; 127(48):2551-7. PubMed ID: 12457324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory experience with physiologically based pharmacokinetic modeling for pediatric drug trials.
    Leong R; Vieira ML; Zhao P; Mulugeta Y; Lee CS; Huang SM; Burckart GJ
    Clin Pharmacol Ther; 2012 May; 91(5):926-31. PubMed ID: 22472993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-label drug use in pediatric anesthesia and intensive care according to official and pediatric reference formularies.
    Doherty DR; Pascuet E; Ni A; Stewart P; Splinter W; Vaillancourt R
    Can J Anaesth; 2010 Dec; 57(12):1078-88. PubMed ID: 20924803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Public financing for off-label use of drugs].
    Hammerman A; Lipschitz Y; Pliskin J; Greenberg D
    Harefuah; 2011 Feb; 150(2):163-7, 204. PubMed ID: 22164947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.